Suppr超能文献

3号染色体p12-p21区域肿瘤抑制基因在透明细胞肾细胞癌中的作用:对VHL依赖和VHL非依赖肿瘤发生途径的分析

Role of chromosome 3p12-p21 tumour suppressor genes in clear cell renal cell carcinoma: analysis of VHL dependent and VHL independent pathways of tumorigenesis.

作者信息

Martinez A, Fullwood P, Kondo K, Kishida T, Yao M, Maher E R, Latif F

机构信息

Department of Paediatrics and Child Health, Medical School, University of Birmingham, Edgbaston, UK.

出版信息

Mol Pathol. 2000 Jun;53(3):137-44. doi: 10.1136/mp.53.3.137.

Abstract

AIMS

Chromosome 3p deletions and loss of heterozygosity (LOH) for 3p markers are features of clear cell renal cell carcinoma but are rare in non-clear cell renal cell carcinoma. The VHL tumour suppressor gene, which maps to 3p25, is a major gatekeeper gene for clear cell renal cell carcinoma and is inactivated in most sporadic cases of this disease. However, it has been suggested that inactivation of other 3p tumour suppressor genes might be crucial for clear cell renal cell carcinoma tumorigenesis, with inactivation (VHL negative) and without inactivation (VHL positive) of the VHL tumour suppressor gene. This study set out to investigate the role of non-VHL tumour suppressor genes in VHL negative and VHL positive clear cell renal cell carcinoma.

METHODS

Eighty two clear cell renal cell carcinomas of known VHL inactivation status were analysed for LOH at polymorphic loci within the candidate crucial regions for chromosome 3p tumour suppressor genes (3p25, LCTSGR1 at 3p21.3, LCTSGR2 at 3p12 and at 3p14.2).

RESULTS

Chromosome 3p12-p21 LOH was frequent both in VHL negative and VHL positive clear cell renal cell carcinoma. However, although the frequency of 3p25 LOH in VHL negative clear cell renal cell carcinoma was similar to that at 3p12-p21, VHL positive tumours demonstrated significantly less LOH at 3p25 than at 3p12-p21. Although there was evidence of LOH for clear cell renal cell carcinoma tumour suppressor genes at 3p21, 3p14.2, and 3p12, both in VHL negative and VHL positive tumours, the major clear cell renal cell carcinoma LOH region mapped to 3p21.3, close to the lung cancer tumour suppressor gene region 1 (LCTSGR1). There was no association between tumour VHL status and tumour grade and stage.

CONCLUSIONS

These findings further indicate that VHL inactivation is not sufficient to initiate clear cell renal cell carcinoma and that loss of a gatekeeper 3p21 tumour suppressor gene is a crucial event for renal cell carcinoma development in both VHL negative and VHL positive clear cell renal cell carcinoma.

摘要

目的

3号染色体短臂缺失及3号染色体短臂(3p)标记杂合性缺失(LOH)是透明细胞肾细胞癌的特征,但在非透明细胞肾细胞癌中罕见。定位于3p25的VHL肿瘤抑制基因是透明细胞肾细胞癌的主要守门基因,在该疾病的大多数散发病例中失活。然而,有人提出,其他3p肿瘤抑制基因的失活可能对透明细胞肾细胞癌的肿瘤发生至关重要,包括VHL肿瘤抑制基因失活(VHL阴性)和未失活(VHL阳性)的情况。本研究旨在探讨非VHL肿瘤抑制基因在VHL阴性和VHL阳性透明细胞肾细胞癌中的作用。

方法

对82例已知VHL失活状态的透明细胞肾细胞癌进行分析,检测3号染色体短臂肿瘤抑制基因(3p25、3p21.3的LCTSGR1、3p12的LCTSGR2和3p14.2)候选关键区域内多态性位点的LOH。

结果

3号染色体短臂12 - p21区域的LOH在VHL阴性和VHL阳性透明细胞肾细胞癌中均很常见。然而,尽管VHL阴性透明细胞肾细胞癌中3p25区域的LOH频率与3p12 - p21区域相似,但VHL阳性肿瘤在3p25区域的LOH明显少于3p12 - p21区域。尽管在VHL阴性和VHL阳性肿瘤中均有证据表明3p21、3p14.2和3p12区域存在透明细胞肾细胞癌肿瘤抑制基因的LOH,但主要的透明细胞肾细胞癌LOH区域定位于3p21.3,靠近肺癌肿瘤抑制基因区域1(LCTSGR1)。肿瘤的VHL状态与肿瘤分级和分期之间无关联。

结论

这些发现进一步表明,VHL失活不足以引发透明细胞肾细胞癌,并且3p21区域一个守门肿瘤抑制基因的缺失是VHL阴性和VHL阳性透明细胞肾细胞癌中肾细胞癌发生发展的关键事件。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验